BlackRock’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-234,225
| Closed | -$265K | – | 5938 |
|
|
2022
Q2 | $265K | Sell |
234,225
-26,449
| -10% | -$29.9K | ﹤0.01% | 4873 |
|
|
2022
Q1 | $1.33M | Sell |
260,674
-778
| -0.3% | -$3.97K | ﹤0.01% | 4474 |
|
|
2021
Q4 | $1.47M | Buy |
261,452
+3,573
| +1% | +$20.1K | ﹤0.01% | 4448 |
|
|
2021
Q3 | $2.86M | Buy |
257,879
+31,498
| +14% | +$349K | ﹤0.01% | 4109 |
|
|
2021
Q2 | $3.84M | Sell |
226,381
-147,473
| -39% | -$2.5M | ﹤0.01% | 3925 |
|
|
2021
Q1 | $9.81M | Buy |
373,854
+26,275
| +8% | +$690K | ﹤0.01% | 3528 |
|
|
2020
Q4 | $12.6M | Buy |
347,579
+17,317
| +5% | +$626K | ﹤0.01% | 3191 |
|
|
2020
Q3 | $11.7M | Buy |
330,262
+141,340
| +75% | +$5M | ﹤0.01% | 3062 |
|
|
2020
Q2 | $8.02M | Sell |
188,922
-340,940
| -64% | -$14.5M | ﹤0.01% | 3243 |
|
|
2020
Q1 | $42.3M | Buy |
529,862
+478,976
| +941% | +$38.2M | ﹤0.01% | 2136 |
|
|
2019
Q4 | $4.71M | Buy |
50,886
+102
| +0.2% | +$9.44K | ﹤0.01% | 3472 |
|
|
2019
Q3 | $3.84M | Buy |
50,784
+1,556
| +3% | +$118K | ﹤0.01% | 3513 |
|
|
2019
Q2 | $4.9M | Buy |
49,228
+48,299
| +5,199% | +$4.81M | ﹤0.01% | 3491 |
|
|
2019
Q1 | $49K | Sell |
929
-59
| -6% | -$3.11K | ﹤0.01% | 4432 |
|
|
2018
Q4 | $62K | Buy |
988
+9
| +0.9% | +$565 | ﹤0.01% | 4398 |
|
|
2018
Q3 | $59K | Buy |
979
+471
| +93% | +$28.4K | ﹤0.01% | 4466 |
|
|
2018
Q2 | $21K | Buy |
508
+432
| +568% | +$17.9K | ﹤0.01% | 4620 |
|
|
2018
Q1 | $8K | Sell |
76
-18
| -19% | -$1.9K | ﹤0.01% | 4630 |
|
|
2017
Q4 | $17K | Buy |
94
+2
| +2% | +$362 | ﹤0.01% | 4533 |
|
|
2017
Q3 | $4K | Buy |
92
+5
| +6% | +$217 | ﹤0.01% | 4709 |
|
|
2017
Q2 | $5K | Sell |
87
-15
| -15% | -$862 | ﹤0.01% | 4727 |
|
|
2017
Q1 | $15K | Buy |
+102
| New | +$15K | ﹤0.01% | 4598 |
|